Accentia Biopharmaceuticals

Accentia Biopharmaceuticals

Advanced Immunotherapeutics

GOVERNANCE
Accentia Biopharmaceuticals is committed to a high standard of business ethics.

Ethical, transparent and lawful conduct of business operation is a shared value of our Board of Directors, management and employees. Critical to our success as we pursue our financial objectives and mindful of the patients we serve, honesty and integrity is never compromised. Consistent with these principles, Accentia has developed Corporate Governance Guidelines and a Code of Conduct and Ethics.

Board of Directors

  • Francis E. O'Donnell, Jr., M.D.

    Chairman and CEO
  • Alan M. Pearce

    Chief Financial Officer
  • David M. Schubert

  • Todd D. Thomason

  • Edmund C. King

  • William S. Poole

  • Christopher C. Chapman, M.D.

Management

  • Francis E. O'Donnell, Jr., M.D.

    Chairman and CEO
  • Samuel S. Duffey, Esq.

    President and General Counsel
  • Alan M. Pearce

    Chief Financial Officer
  • Carlos F. Santos, Ph.D.

    Chief Scientific Officer